News

      January 15, 2024 News

      Oblique Therapeutics presents at Redeye

      Oblique Therapeutics presents at Redeye

      Read more

      November 28, 2023 News

      Oblique Therapeutics forms strategic collaboration with AAX Biotech

      Read more

      November 17, 2023 News

      Oblique Therapeutics enters an agreement with a large US-based pharmaceutical company

      Read more

      October 10, 2023 News

      Oblique Therapeutics presents at the Redeye Neurology Theme Event

      Event at Redeye, January 16 at Redeye – Stockholm

      Read more

      March 8, 2023 News

      Report launch: The Swedish Drug Discovery and Development Pipeline 2023

      SwedenBIO launches the long-awaited 2023 edition of the large, recurring mapping of the Swedish pharmaceutical pipeline.

      Read more

      February 8, 2023 News

      Oblique Therapeutics offentliggör utfall i genomförd företrädesemission

      Read more

      January 30, 2023 Event

      Oblique Therapeutics is pleased to be participating in the Biotechgate Digital Partnering event

      Virtual Business development and Licensing event - Feb 6 -10, 2023

      Read more

      January 4, 2023 News

      Announcement of Oblique Therapeutics ‘s Rights Issue 2023

      Read more

      January 3, 2023 Event

      Oblique Therapeutics is thrilled to be attending in person at the 41st Annual J.P. Morgan Healthcare Conference

      January 9—12, 2023 | San Francisco, CA

      Read more

      December 22, 2022 Event

      Oblique Therapeutics is pleased to take part digitally to the next BIO Partnering JPM Week: January 9-12, 2023

      Read more
      1 2 3 7